First RayStation order in France
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from the Lucien Neuwirth Institute of Cancerology (ICLN – Institut de Cancérologie Lucien Neuwirth) in Saint Priest en Jarez, France.
ICLN is a public hospital specialized in cancer treatment and is part of the Saint Etienne University Campus. The institute offers state-of-the-art cancer treatments using chemotherapy and advanced radiation therapy and treats 1,900 patients annually.
The institute will primarily use RayStation® as a complement to the existing treatment planning system to perform advanced techniques such as adaptive radiation therapy or planning of IMRT treatments using multi-criteria optimization.
Mustapha Khodri, Head of the Physics department at ICLN comments: “We are always seeking to improve our treatments and are very interested in new treatment techniques. RayStation® offers a wide range of advanced and unique tools with significant potential to improve the treatment quality and make the workflow more efficient in the radiotherapy department. We are eager to start operating the system for clinical use”.
Professor Nicolas Magné, Head of ICLN’s Department of Radiotherapy and Director of Research and Innovation, says: “Being the first in France to have RayStation® is a real opportunity to develop our research programs. We aim to produce results that can be applied immediately in our daily clinical practice and are looking forward to work together with RaySearch to ensure that our patients get the very best treatments”.
“We are expanding our European operations and we are very happy to present our first customer in France. ICLN is one of the best research centers in France. They are at the forefront of the development of new treatment techniques so we are thrilled that they selected RayStation® as their tool for advanced treatment planning applications,” says Johan Löf, CEO of RaySearch Laboratories AB.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for both photon and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian and Accuray. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,000 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30